Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T
Abstract
Purpose: Cystathionine (Cth) has emerged as a promising biomarker for identifying 1p/19q codeleted gliomas. However, little is known about the T2 relaxation time constant of Cth in gliomas. The aim of this study was to measure the T2 of Cth in vivo in glioma and compare it to the T2s of other metabolites at 3 T. Methods: Ten participants with glioma were scanned at 3 T. Single-voxel proton PRESS spectra were acquired at four echo-times to determine the T2 relaxation time constants of Cth, N-acetylaspartate, scyllo-inositol, total creatine, and total choline. Processed spectra were analyzed using LCModel, and the results were fitted using a mono-exponential function to estimate the T2 relaxation time constants. T2 of Cth was also measured using high-resolution NMR. Results: The T2 of Cth varied across participants (42–128 ms, with a mean and standard deviation of 75 ± 24 ms). Additionally, T2 relaxation time constants of Cth were shorter than those of singlets measured in glioma in the same participants. Distinct differences in T2 between the CH and CH2 proton groups in Cth were also observed both in vitro and in vivo. Conclusion: Knowledge of the T2 of Cth should improve its quantification and may help increase understanding of the intracellular environment in glioma cells, potentially providing insights into tumor metabolism in future studies.
Related
- Rhinovirus C15 Attenuates Relaxation and cAMP Production in Human Airways and Smooth Muscle
- Routing to the seizure in postoperative human glioma cortex: spatio-temporal uncoupling between slow and fast extracellular neuronal activities
- Experimental Framework to Investigate Glioma in Organotypic Human Cortex
- Histopathology-correlated evaluation of magnetic resonance spectroscopy for high-grade glioma prediction: A small-scale neuro-oncology study with exploratory machine learning
- 1111 NIR light mediated mechanical destruction of glioma cells to trigger tumor antigen release and potentiate immunogenic cell death
BibTeX
@article{deelchand2026transverse,
title = {{Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T}},
author = {Dinesh K Deelchand and Francesca Branzoli and Jamie D Walls and Lucia Nichelli and Marc Sanson and Bertrand Mathon and Małgorzata Marjańska},
journal = {Magnetic Resonance in Medicine},
year = {2026},
month = may,
doi = {10.1002/mrm.70430},
url = {https://hal.science/hal-05732951v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T
AU - Dinesh K Deelchand
AU - Francesca Branzoli
AU - Jamie D Walls
AU - Lucia Nichelli
AU - Marc Sanson
AU - Bertrand Mathon
AU - Małgorzata Marjańska
PY - 2026
DA - 2026/05/20
JO - Magnetic Resonance in Medicine
DO - 10.1002/mrm.70430
UR - https://hal.science/hal-05732951v1
AB - Purpose: Cystathionine (Cth) has emerged as a promising biomarker for identifying 1p/19q codeleted gliomas. However, little is known about the T2 relaxation time constant of Cth in gliomas. The aim of this study was to measure the T2 of Cth in vivo in glioma and compare it to the T2s of other metabolites at 3 T. Methods: Ten participants with glioma were scanned at 3 T. Single-voxel proton PRESS spectra were acquired at four echo-times to determine the T2 relaxation time constants of Cth, N-acetylaspartate, scyllo-inositol, total creatine, and total choline. Processed spectra were analyzed using LCModel, and the results were fitted using a mono-exponential function to estimate the T2 relaxation time constants. T2 of Cth was also measured using high-resolution NMR. Results: The T2 of Cth varied across participants (42–128 ms, with a mean and standard deviation of 75 ± 24 ms). Additionally, T2 relaxation time constants of Cth were shorter than those of singlets measured in glioma in the same participants. Distinct differences in T2 between the CH and CH2 proton groups in Cth were also observed both in vitro and in vivo. Conclusion: Knowledge of the T2 of Cth should improve its quantification and may help increase understanding of the intracellular environment in glioma cells, potentially providing insights into tumor metabolism in future studies.
SN - 0740-3194
SN - 1522-2594
ER -